{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:45:50Z","timestamp":1793295950980,"version":"4.5.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fully automated interferon gamma release assays based on chemiluminescence immunoassay promise more efficient testing for tuberculosis infection but increase rates of positive test results when compared with semiautomated assays. We report an increase in borderline-positive interferon gamma release assay results (87.8% relative increase; 95% CI, 31.1%\u2013170.0%), which led to modifications in clinical care following chemiluminescence immunoassay implementation.<\/jats:p>","DOI":"10.1093\/ofid\/ofag234","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:30:49Z","timestamp":1776771049000},"source":"Crossref","is-referenced-by-count":1,"title":["Real-World Outcomes of Chemiluminescence Immunoassay Implementation for\n                    <i>Mycobacterium tuberculosis<\/i>\n                    Infection Screening"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-2681","authenticated-orcid":false,"given":"Eli","family":"Wilber","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos C","family":"Schechter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-063X","authenticated-orcid":false,"given":"Paulina A","family":"Rebolledo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]},{"name":"Hubert Department of Global Health, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Kandiah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3034-9947","authenticated-orcid":false,"given":"Bruce","family":"Aldred","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-4866","authenticated-orcid":false,"given":"Yun F","family":"Wang","sequence":"additional","affiliation":[{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Ray","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026052213571606100_ofag234-B1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026052213571606100_ofag234-B2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3343\/alm.2020.40.1.33","article-title":"Performance evaluation of a new automated chemiluminescent immunoanalyzer-based interferon-gamma releasing assay AdvanSure I3 in comparison with the QuantiFERON-TB Gold In-Tube assay","volume":"40","author":"Kim","year":"2020","journal-title":"Ann Lab Med"},{"key":"2026052213571606100_ofag234-B3","doi-asserted-by":"crossref","first-page":"e0046924","DOI":"10.1128\/spectrum.00469-24","article-title":"Evaluation of concordance of new QuantiFERON-TB Gold Plus platforms for Mycobacterium tuberculosis infection diagnosis in a prospective cohort of household contacts","volume":"12","author":"Ruiz-Tagle","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2026052213571606100_ofag234-B4","doi-asserted-by":"crossref","first-page":"113340","DOI":"10.1016\/j.jim.2022.113340","article-title":"Repeatability of QuantiFERON-TB Gold Plus testing utilizing microparticle chemiluminescence","volume":"509","author":"Cornaby","year":"2022","journal-title":"J Immunol Methods"},{"key":"2026052213571606100_ofag234-B5","doi-asserted-by":"crossref","first-page":"e0060321","DOI":"10.1128\/JCM.00603-21","article-title":"Evaluation of the fully automated chemiluminescence analyzer Liaison XL for the performance of the QuantiFERON-TB Gold Plus assay in an area with a low incidence of tuberculosis","volume":"59","author":"Fern\u00e1ndez-Huerta","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026052213571606100_ofag234-B6","doi-asserted-by":"crossref","first-page":"e00159-20","DOI":"10.1128\/JCM.00159-20","article-title":"Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a low-tuberculosis-incidence setting","volume":"58","author":"De Maertelaere","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026052213571606100_ofag234-B7","doi-asserted-by":"crossref","first-page":"e0029523","DOI":"10.1128\/jcm.00295-23","article-title":"Inflated gamma interferon response with QuantiFERON-TB Gold Plus using the automated Liaison XL analyzer: a testing algorithm to mitigate false-positive results in low-incidence settings","volume":"61","author":"Buron","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026052213571606100_ofag234-B8","doi-asserted-by":"crossref","first-page":"e00780","DOI":"10.1128\/JCM.00780-20","article-title":"QuantiFERON-TB Gold Plus with chemiluminescence immunoassay: do we need a higher cutoff?","volume":"58","author":"Bisognin","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026052213571606100_ofag234-B9","author":"US Census Bureau"},{"key":"2026052213571606100_ofag234-B10","doi-asserted-by":"crossref","first-page":"e0187924","DOI":"10.1128\/jcm.01879-24","article-title":"Impact of an analytical intervention to assure the accuracy of LIAISON QuantiFERON-TB Gold Plus results","volume":"63","author":"Pusz-Bochenska","year":"2025","journal-title":"J Clin Microbiol"},{"key":"2026052213571606100_ofag234-B11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/ice.2023.5","article-title":"Principles of diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force","volume":"44","author":"Fabre","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026052213571606100_ofag234-B12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/ciae357","article-title":"Conversion or reversion of interferon \u03b3 release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"80","author":"Wang","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026052213571606100_ofag234-B13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052213571606100_ofag234-B14","doi-asserted-by":"crossref","first-page":"h2750","DOI":"10.1136\/bmj.h2750","article-title":"Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis","volume":"350","author":"Kontopantelis","year":"2015","journal-title":"BMJ"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag234\/68135972\/ofag234.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/5\/ofag234\/68135972\/ofag234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/5\/ofag234\/68135972\/ofag234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:57:26Z","timestamp":1779472646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag234\/8660881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag234","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,22]]},"article-number":"ofag234"}}